首页|期刊导航|癌症（英文版）|Ailanthone: a new potential drug for castration-resistant prostate cancer

Ailanthone: a new potential drug for castration-resistant prostate cancer

Shihong Peng Zhengfang Yi Mingyao Liu

癌症（英文版）2017，Vol.36Issue(5)：207-208,2.

癌症（英文版）2017，Vol.36Issue(5)：207-208,2.DOI:10.1186/s40880-017-0194-7

Ailanthone: a new potential drug for castration-resistant prostate cancer

Shihong Peng ¹Zhengfang Yi ¹Mingyao Liu¹

作者信息

1. East China Normal University and Shanghai Fengxian District Central Hospital Joint Center for Translational Medicine, Shanghai Key Laboratory of Regula-tory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Rd, Shanghai 200241, P.R. China
折叠

摘要

引用本文复制引用

Shihong Peng,Zhengfang Yi,Mingyao Liu..Ailanthone: a new potential drug for castration-resistant prostate cancer[J].癌症（英文版）,2017,36(5):207-208,2.

基金项目

This study was partially supported by Major State Basic Research Develop-ment Program of China (Nos. 2015CB910400 and 2012CB910400) and National Natural Science Foundation of China (Nos. 81472788 and 81272463). （Nos. 2015CB910400 and 2012CB910400）

癌症（英文版）

OACSCDCSTPCDSCI

ISSN：1000-467X

访问量0

下载量0

段落导航